Inhaled Sodium Nitrite Improves Rest and Exercise Hemodynamics in Heart Failure with Preserved Ejection Fraction

Circulation Research

Volumn 119, Issue 7, 2016, Pages 880-886

  Borlaug, Barry A ^a   Melenovsky, Vojtech ^a   Koepp, Katlyn E ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

exercise; heart failure; hemodynamics; nitrate; nitric oxide

Indexed keywords

PLACEBO; SODIUM NITRITE;

AGED; ARTERY COMPLIANCE; ARTICLE; BLOOD SAMPLING; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG HALF LIFE; DRUG SAFETY; EXERCISE; FEMALE; GAS ANALYSIS; HEADACHE; HEART CATHETERIZATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HEART STROKE VOLUME; HUMAN; HYPOTENSION; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL; REST; DRUG EFFECTS; HEART FAILURE; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VERY ELDERLY;

ADMINISTRATION, INHALATION; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; REST; SODIUM NITRITE; STROKE VOLUME;

EID: 84988378392     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.309184     Document Type: Article

References (31)

1. Sharma K, Kass DA, Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res 2014 115 79 96. doi: 10.1161/CIRCRESAHA.115.302922
2. Borlaug BA, Paulus WJ, Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment. Eur Heart J 2011 32 670 679. doi: 10.1093/eurheartj/ehq426
3. Borlaug BA, Nishimura RA, Sorajja P, Lam CS, Redfield MM, Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010 3 588 595. doi: 10.1161/CIRCHEARTFAILURE.109.930701
4. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM, Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010 56 855 863. doi: 10.1016/j.jacc.2010.04.040
5. Andersen MJ, Olson TP, Melenovsky V, Kane GC, Borlaug BA, Differential hemodynamic effects of exercise and volume expansion in people with and without heart failure. Circ Heart Fail 2015 8 41 48. doi: 10.1161/CIRCHEARTFAILURE.114.001731
6. Paulus WJ, Tschöpe C, A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 2013 62 263 271. doi: 10.1016/j.jacc.2013.02.092
7. Vanderpool R, Gladwin MT, Harnessing the nitrate-nitrite-nitric oxide pathway for therapy of heart failure with preserved ejection fraction. Circulation 2015 131 334 336. doi: 10.1161/CIRCULATIONAHA.114.014149
8. Borlaug BA, Koepp KE, Melenovsky V, Sodium Nitrite Improves Exercise Hemodynamics and Ventricular Performance in Heart Failure With Preserved Ejection Fraction. J Am Coll Cardiol 2015 66 1672 1682. doi: 10.1016/j.jacc.2015.07.067
9. Rix PJ, Vick A, Attkins NJ, Barker GE, Bott AW, Alcorn H Jr, Gladwin MT, Shiva S, Bradley S, Hussaini A, Hoye WL, Parsley EL, Masamune H, Pharmacokinetics, pharmacodynamics, safety, and tolerability of nebulized sodium nitrite (AIR001) following repeat-dose inhalation in healthy subjects. Clin Pharmacokinet 2015 54 261 272. doi: 10.1007/s40262-014-0201-y
10. Rau JL, Ari A, Restrepo RD, Performance comparison of nebulizer designs: constant-output, breath-enhanced, and dosimetric. Respir Care 2004 49 174 179
11. Labiris NR, Dolovich MB, Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications. Br J Clin Pharmacol 2003 56 588 599
12. Borlaug BA, The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2014 11 507 515. doi: 10.1038/nrcardio.2014.83
13. Melenovsky V, Hwang SJ, Lin G, Redfield MM, Borlaug BA, Right heart dysfunction in heart failure with preserved ejection fraction. Eur Heart J 2014 35 3452 3462. doi: 10.1093/eurheartj/ehu193
14. Dorfs S, Zeh W, Hochholzer W, Jander N, Kienzle RP, Pieske B, Neumann FJ, Pulmonary capillary wedge pressure during exercise and long-term mortality in patients with suspected heart failure with preserved ejection fraction. Eur Heart J 2014 35 3103 3112. doi: 10.1093/eurheartj/ehu315
15. Greene SJ, Gheorghiade M, Borlaug BA, Pieske B, Vaduganathan M, Burnett JC Jr, Roessig L, Stasch JP, Solomon SD, Paulus WJ, Butler J, The cGMP signaling pathway as a therapeutic target in heart failure with preserved ejection fraction. J Am Heart Assoc 2013 2 e000536. doi: 10.1161/JAHA.113.000536
16. Redfield MM, Anstrom KJ, Levine JA, NHLBI Heart Failure Clinical Research Network Isosorbide mononitrate in heart failure with preserved ejection fraction. N Engl J Med 2015 373 2314 2324. doi: 10.1056/NEJMoa1510774
17. Münzel T, Daiber A, Gori T, Nitrate therapy: new aspects concerning molecular action and tolerance. Circulation 2011 123 2132 2144. doi: 10.1161/CIRCULATIONAHA.110.981407
18. Thomas GR, DiFabio JM, Gori T, Parker JD, Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanism. J Am Coll Cardiol 2007 49 1289 1295. doi: 10.1016/j.jacc.2006.10.074
19. Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, Johnson BD, Redfield MM, Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol 2010 56 845 854. doi: 10.1016/j.jacc.2010.03.077
20. Akiyama E, Sugiyama S, Matsuzawa Y, Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2012 60 1778 1786. doi: 10.1016/j.jacc.2012.07.036
21. Lundberg JO, Weitzberg E, Gladwin MT, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008 7 156 167. doi: 10.1038/nrd2466
22. Zamani P, Rawat D, Shiva-Kumar P, Geraci S, Bhuva R, Konda P, Doulias PT, Ischiropoulos H, Townsend RR, Margulies KB, Cappola TP, Poole DC, Chirinos JA, Effect of inorganic nitrate on exercise capacity in heart failure with preserved ejection fraction. Circulation 2015 131 371 380; discussion 380. doi: 10.1161/CIRCULATIONAHA.114.012957
23. Eggebeen J, Kim-Shapiro DB, Haykowsky M, Morgan TM, Basu S, Brubaker P, Rejeski J, Kitzman DW, One week of daily dosing with beetroot juice improves submaximal endurance and blood pressure in older patients with heart failure and preserved ejection fraction. JACC Heart Fail 2016 4 428 437. doi: 10.1016/j.jchf.2015.12.013
24. Bhushan S, Kondo K, Polhemus DJ, Otsuka H, Nicholson CK, Tao YX, Huang H, Georgiopoulou VV, Murohara T, Calvert JW, Butler J, Lefer DJ, Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling. Circ Res 2014 114 1281 1291. doi: 10.1161/CIRCRESAHA.114.301475
25. Lai YC, Tabima DM, Dube JJ, Hughan KS, Vanderpool RR, Goncharov DA, St Croix CM, Garcia-Ocaña A, Goncharova EA, Tofovic SP, Mora AL, Gladwin MT, SIRT3-AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction. Circulation 2016 133 717 731. doi: 10.1161/CIRCULATIONAHA.115.018935
26. Ormerod JO, Arif S, Mukadam M, Evans JD, Beadle R, Fernandez BO, Bonser RS, Feelisch M, Madhani M, Frenneaux MP, Short-term intravenous sodium nitrite infusion improves cardiac and pulmonary hemodynamics in heart failure patients. Circ Heart Fail 2015 8 565 571. doi: 10.1161/CIRCHEARTFAILURE.114.001716
27. Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, Macallister R, Hobbs AJ, Webb AJ, Ahluwalia A, Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010 56 274 281. doi: 10.1161/HYPERTENSIONAHA.110.153536
28. Zuckerbraun BS, Shiva S, Ifedigbo E, Mathier MA, Mollen KP, Rao J, Bauer PM, Choi JJ, Curtis E, Choi AM, Gladwin MT, Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation 2010 121 98 109. doi: 10.1161/CIRCULATIONAHA.109.891077
29. Ingram TE, Pinder AG, Bailey DM, Fraser AG, James PE, Low-dose sodium nitrite vasodilates hypoxic human pulmonary vasculature by a means that is not dependent on a simultaneous elevation in plasma nitrite. Am J Physiol Heart Circ Physiol 2010 298 H331 H339. doi: 10.1152/ajpheart.00583.2009
30. Sparacino-Watkins CE, Lai YC, Gladwin MT, Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics. Circulation 2012 125 2824 2826. doi: 10.1161/CIRCULATIONAHA.112.107821
31. Thadani U, Parker JO, Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects. Am J Cardiol 1978 41 52 59